An Interactive Experience for SU2C
Overview
Stand Up To Cancer is a nonprofit whose mission is to raise funds to accelerate the pace of groundbreaking cancer research that can provide new therapies to patients quickly and save lives. Thanks to celebrity ambassadors, the nonprofit already had strong brand recognition all over the world.
In an effort to showcase Stand Up to Cancer’s impact on research and patients, we created an interactive experience that distilled large amounts of data and content to engage stakeholders, donors and potential partnerships.
PROJECT
Landing page
MY ROLE
Strategy, UX ideation, website UI, and
front-end QA
TEAM
Senior UI / UX Designer (myself)
Creative Director
Copywriter
Front-end Developer
Project Manager
Creating the Experience
To create a compelling experience for stakeholders, potential donors and partners, we had to understand what data and content should be visualized to tell the story.
Our strategy was to break down large amounts of research into more digestible segments. We structured the experience into specific topic areas that would occupy the entire viewport of the user’s device. The page was broken down into the following sections:
The SU2C Model: Explaining the Stand Up To Cancer research model
The Entertainment Industry: The influence of celebrity ambassadors
Technology: Latest and greatest technology to fuel the research
Results: How the research has accelerated new treatments and bringing them to patients faster
Impacting Lives: Real patient stories of SU2C’s impact on their lives
To engage visitors with captivating storytelling, we added interactions to the typography and data visualizations.
Final Thoughts and Impact
Ultimately, the challenge with this project was finding a method to visualize data and content to strike an emotional cord with our core audiences. It proves that the most successful fundraising happens at the intersection of art and science, driven by powerful storytelling.
The launch of the SU2C Impact Report has contributed to an increase in funding clinical trials and enabled the research of more than 1,600 scientists.
SEE MORE WORK